Dr. William M. Dugan Jr., M.D.

Expert Publications

• Oncology staff recognition of depressive symptoms on videotaped interviews of depressed cancer patients: implications for designing a training program.
• Clinical Oncology Program: a community cancer control model.
• Clinical Oncology Program: a community cancer control model.
• An attempt to employ the Zung Self-Rating Depression Scale as a "lab test" to trigger follow-up in ambulatory oncology clinics: criterion validity and detection.
• Access to communication technologies in a sample of cancer patients: an urban and rural survey.
• Clinical alternatives to radical mastectomy.
• Clinical alternatives to radical mastectomy.
• Back pain: the primrose path--a case report.
• Cancer corner.
• Continuous infusion metoclopramide: clinical trials, pharmacokinetic considerations and cost-effectiveness.
• Reliability of videotape technology in assessing the efficacy of anti-emetic drugs.
• The value of dexamethasone when added to combination drug therapy in the prevention of cisplatin-induced nausea and vomiting, evaluated by time-lapse video technology.
• Oncology waste management.
• Comment: revised treatment of ulcerative stomatitis.
• Colorectal cancer: screening, detection.

Media Releases

Get to know Hematologist-Oncologist Dr. William M. Dugan Jr., who serves patients throughout the State of Indiana.

A hematologist-oncologist, Dr. Dugan Jr. is a cancer specialist trained in blood disorders and the medical treatment of malignancies.

In the state of Indiana, he is affiliated with Columbus Regional Hospital, Community Hospital East, Community Hospital North, Woodlawn Hospital, Margaret Mary Health, Indiana University Health University Hospital, and Parkview Wabash Hospital.

“I’ve been a practicing medical oncologist for over 36 years, and the most gratifying work I have done is what I do in the rural hospital setting every week. Hardly a day goes by that a patient doesn’t thank me for not having to drive long distances to receive cancer care” expressed the doctor. 

Graduating with the class of 1963 at the Indiana University School of Medicine, Dr. Dugan Jr. went on to further his studies. He performed his internship, residency in internal medicine, and fellowship in hematology and medical oncology at the said establishment in 1964, 1967, and 1968, respectively. 

A provider of educational programs to patients, families, physicians and nurses, he served as the co-founder and president of Community Cancer Care in Indianapolis, an assistant clinical professor at the Indiana University School of Medicine, and as the co-founder of the Quality of Life Foundation.

An active cancer researcher, Dr. Dugan Jr. is board-certified in medical oncology and internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Obtaining membership status, he is an active member of the American Society of Clinical Oncology.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, and sickle-cell disease.

Recognized for his work, Dr. Dugan Jr. is the 2005 recipient of the Rural Health Practitioner of the Year Award. National Rural Health Association’s 28th Annual Conference in New Orleans, the award recognizes the rural health leader whose dedication and commitment exemplifies the highest standards of rural health care and service. 

Dr. Dugan was honored for his outstanding contributions made to health care in rural areas for over 23 years, and is the first specialist to win the award.

Recommended Articles

• How This Survivor Star Beat Hodgkin Lymphoma—Twice

  Ethan Zohn is a survivor in many ways. In 2002, he outlasted 15 fiercely strong competitors on the popular TV show, Survivor: Africa. His strength, wit, athleticism, and perseverance won him a million-dollar prize after he defeated these opponents. However, his victory was short-lived. Little did he...

• Make-A-Wish Makes a Movie Star

  Through their fundraising, on average in the United States and its territories, Make-A-Wish is able to grant the wish of a child every 34 minutes.How was it started?The Make-A-Wish Foundation started with the wish of one 7-year-old boy’s wish in 1980. Chris Grecius, who had leukemia, wanted to be...

• What Specialists Treat Multiple Myeloma?

  If you suffer from multiple myeloma, which a rare form of blood cancer, one of the most crucial decisions you will have to make is choosing a doctor who specializes in multiple myeloma. A hematologist-oncologist is the specialist you need who will manage your cancer throughout the cycle of...

• A Triathlon for Bloodwise

  Where would anyone be without friends? There have been many experiences where friends have been a bit of light in the dark. When 30-year-old Alexandra “Pixie” Flather from a town near Aylsham, England found out that her best friend was diagnosed with Leukemia, she decided to take action. At the...

• Dreams Do Come True: 9-year-old Baseball Fanatic Signed Onto Team

  Like most young baseball fans, John “Parker” Staples' room is covered in memorabilia from his favorite team, the Washington Nationals, but unlike most kids, Parker's room is at the University of Virginia Children's Hospital.John “Parker” Staples, is nine-year old who was diagnosed with...

• How Dogs Are Helping with Lymphoma Research

  According to the Cornell Chronicle (CC), Cornell and Tufts University have received a huge grant for the study of human lymphoma, using a humane approach to test on dogs.The dogs in the study will already have lymphoma and it’s hoped they’ll be cured in the process of this research study.There...